GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms-Reference-Cited by-同舟云学术

GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms

Published:2022-02 Issue:2 Volume:28 Page:96.e1-96.e11
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Malagola Michele^ORCID,Polverelli Nicola,Rubini Vicky,Martino Massimo^ORCID,Patriarca Francesca,Bruno Benedetto,Giaccone Luisa,Grillo Giovanni,Bramanti Stefania,Bernasconi Paolo,De Gobbi Marco,Natale Annalisa,Terruzzi Elisabetta,Olivieri Attilio,Chiusolo Patrizia,Carella Angelo Michele,Casini Marco,Nozzoli Chiara,Mazza Patrizio,Bassi Simona,Onida Francesco^ORCID,Vacca Adriana,Falcioni Sadia,Luppi Mario,Iori Anna Paola,Pavone Vincenzo,Skert Cristina,Carluccio Paola,Borghero Carlo,Proia Anna,Selleri Carmine,Sacchi Nicoletta,Mammoliti Sonia,Oldani Elena,Ciceri Fabio,Russo Domenico,Bonifazi Francesca

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference37 articles.

1. Hematopoietic stem cell transplantation for blood cancers in the era of precision medicine and immunotherapy;Bair;Cancer,2020

2. Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia of the Elderly: Review of Literature and New Perspectives;Magliano;Mediterr J Hematol Infect Dis,2020

3. What have we learned from transplanting older patients?;Varadarajan;Best Pract Res Clin Haematol,2019

4. https://www.gitmo.it/index.php/report-trapianti-annuali.

5. https://www.istat.it.

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis Aged 70 Years or Older: A Study from the German Registry for Stem Cell Transplantation;Transplantation and Cellular Therapy;2024-08

2. Impact of busulfan versus treosulfan dose intensity in myelofibrosis undergoing hematopoietic cell transplantation;American Journal of Hematology;2024-05-14

3. Treosulfan is a safe and effective alternative to busulfan for conditioning in adult allogeneic HSCT patients: Data from a single center;Cancer Medicine;2024-05

4. How I reduce and treat posttransplant relapse of MDS;Blood;2024-04-04

5. Donor Lymphocyte Infusion in the Treatment of Post-Transplant Relapse of Acute Myeloid Leukemias and Myelodysplastic Syndromes Significantly Improves Overall Survival: A French–Italian Experience of 134 Patients;Cancers;2024-03-26